Amy Finkelstein

Q: What Schools Are Affiliated With Amy Finkelstein

Amy Finkelstein is affiliated with the following schools: University of Oxford, Massachusetts Institute of Technology, Harvard University

Amy Finkelstein's AcademicInfluence.com Rankings

Amy Finkelstein

Economics

#364

World Rank

#458

Historical Rank

#227

USA Rank

economics Degrees

Download Badge

Economics

Why Is Amy Finkelstein Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Amy Nadya Finkelstein is a professor of economics at the Massachusetts Institute of Technology , the co-director and research associate of the Public Economics Program at the National Bureau of Economic Research, and the co-Scientific Director of J-PAL North America. She was awarded the 2012 John Bates Clark Medal for her contributions to economics. She was elected to the National Academy of Sciences and won a MacArthur "Genius" fellowship in 2018.

(See a Problem?)

Amy Finkelstein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Oregon experiment--effects of Medicaid on clinical outcomes. (2013) (990)
Multiple Dimensions of Private Information: Evidence from the Long-Term Care Insurance Market. (2006) (694)
Adverse Selection in Insurance Markets: Policyholder Evidence from the U.K. Annuity Market (2000) (648)
E-Ztax: Tax Salience and Tax Rates (2007) (566)
Medicaid Increases Emergency-Department Use: Evidence from Oregon's Health Insurance Experiment (2014) (531)
The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare (2005) (495)
Selection on Moral Hazard in Health Insurance (2011) (382)
Estimating Welfare in Insurance Markets Using Variation in Prices (2008) (374)
What did Medicare do? The initial impact of Medicare on mortality and out of pocket medical spending (2008) (369)
Sources of Geographic Variation in Health Care: Evidence from Patient Migration (2014) (343)
Selection Effects in the United Kingdom Individual Annuities Market (2002) (304)
Selection in Insurance Markets: Theory and Empirics in Pictures (2011) (285)
Why Is the Market or Long-term Care Insurance So Small? (2007) (285)
The Economic Consequences of Hospital Admissions (2016) (261)
Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry (2004) (245)
Income and Health Spending: Evidence from Oil Price Shocks (2009) (238)
The Rand Health Insurance Experiment, Three Decades Later (2012) (226)
Preference Heterogeneity and Insurance Markets: Explaining a Puzzle of Insurance (2008) (222)
Beyond Testing: Empirical Models of Insurance Markets (2009) (220)
How General are Risk Preferences? Choices Under Uncertainty in Different Domains (2010) (214)
The Private Market for Long-Term Care Insurance in the United States: A Review of the Evidence (2009) (212)
Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector (2006) (175)
Take-Up and Targeting: Experimental Evidence from Snap (2018) (161)
Health Care Hotspotting - A Randomized, Controlled Trial. (2020) (156)
Insuring long-term care in the United States (2011) (151)
The effects of Medicaid coverage--learning from the Oregon experiment. (2011) (149)
THE RESPONSE OF DRUG EXPENDITURE TO NON-LINEAR CONTRACT DESIGN: EVIDENCE FROM MEDICARE PART D. (2015) (149)
The Welfare Cost of Asymmetric Information: Evidence from the U.K. Annuity Market (2007) (147)
The Value of Medicaid: Interpreting Results from the Oregon Health Insurance Experiment (2015) (142)
Social Insurance: Connecting Theory to Data (2012) (136)
EZ-Tax: Tax Salience and Tax Rates (2009) (124)
Moral Hazard in Health Insurance: What We Know and How We Know It (2017) (123)
Mandatory Medicare Bundled Payment Program for Lower Extremity Joint Replacement and Discharge to Institutional Postacute Care: Interim Analysis of the First Year of a 5-Year Randomized Trial (2018) (121)
Health Care Exceptionalism? Performance and Allocation in the US Health Care Sector. (2016) (120)
Subsidizing Health Insurance for Low-Income Adults: Evidence from Massachusetts. (2017) (120)
The effect of tax subsidies to employer-provided supplementary health insurance: evidence from Canada (2002) (110)
Testing for Adverse Selection with “Unused Observables” (2006) (109)
Selection Effects in the Market for Individual Annuities: New Evidence from the United Kingdom (1999) (102)
THE IMPACT OF HEALTH INSURANCE EXPANSIONS ON OTHER SOCIAL SAFETY NET PROGRAMS ‡ The Impact of Medicaid on Labor Market Activity and Program Participation: Evidence from the Oregon Health Insurance Experiment † (2014) (100)
Testing for Asymmetric Information Using 'Unused Observables' in Insurance Markets: Evidence from the U.K. Annuity Market (2006) (97)
Moral Hazard in Health Insurance: Do Dynamic Incentives Matter? (2015) (94)
Effect of Medicaid Coverage on ED Use - Further Evidence from Oregon's Experiment. (2016) (92)
Predictive modeling of U.S. health care spending in late life (2018) (90)
Did Medicare Induce Pharmaceutical Innovation? (2006) (81)
Healthcare Exceptionalism? Performance and Allocation in the U.S. Healthcare Sector (2015) (79)
Provider Incentives and Healthcare Costs: Evidence from Long-Term Care Hospitals (2017) (73)
Moral Hazard in Health Insurance: How Important is Forward Looking Behavior? (2012) (71)
What the Oregon health study can tell us about expanding Medicaid. (2010) (71)
Peer Effects in the Workplace: Evidence from Random Groupings in Professional Golf Tournaments † (2009) (68)
Place-Based Drivers of Mortality: Evidence from Migration (2019) (66)
What Did Medicare Do (and Was it Worth it)? (2005) (62)
Health Care Spending and Utilization in Public and Private Medicare. (2019) (62)
Minimum standards, insurance regulation and adverse selection: evidence from the Medigap market (2004) (61)
Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D (2016) (61)
Initial economic damage from the COVID-19 pandemic in the United States is more widespread across ages and geographies than initial mortality impacts (2020) (58)
The Uninsured Do Not Use The Emergency Department More-They Use Other Care Less. (2017) (55)
Bunching at the Kink: Implications for Spending Responses to Health Insurance Contracts (2016) (54)
INCREASING HEALTH INSURANCE COSTS AND THE DECLINE IN INSURANCE COVERAGE (2004) (49)
Racial Disparities In Excess All-Cause Mortality During The Early COVID-19 Pandemic Varied Substantially Across States. (2021) (46)
The Private Market for Long-Term Care Insurance in the U.S.: A Review of the Evidence. (2009) (45)
Medicare Letters To Curb Overprescribing Of Controlled Substances Had No Detectable Effect On Providers. (2016) (43)
Moral Hazard in Health Insurance (2014) (42)
In Praise of Moderation: Suggestions for the Scope and Use of Pre-Analysis Plans for Rcts in Economics (2020) (41)
Adjusting Risk Adjustment - Accounting for Variation in Diagnostic Intensity. (2017) (41)
Outpatient Office Wait Times And Quality Of Care For Medicaid Patients. (2017) (41)
Paying on the Margin for Medical Care: Evidence from Breast Cancer Treatments (2014) (38)
The Interaction of Partial Public Insurance Programs and Residual Private Insurance Markets: Evidence from the U.S. Medicare Program (2002) (37)
What Does (Formal) Health Insurance Do, and for Whom? (2017) (36)
Clinical decision support for high-cost imaging: A randomized clinical trial (2019) (32)
The Impact of Medicaid Expansion on Voter Participation: Evidence from the Oregon Health Insurance Experiment (2018) (32)
Healthcare Spending and Utilization in Public and Private Medicare (2017) (32)
Insuring Long Term Care in the Us (2011) (31)
The Effect of Medicaid on Management of Depression: Evidence From the Oregon Health Insurance Experiment (2018) (29)
Beyond Statistics: The Economic Content of Risk Scores (2015) (28)
What Drives Prescription Opioid Abuse? Evidence from Migration (2018) (27)
The Effect Of Medicaid On Medication Use Among Poor Adults: Evidence From Oregon. (2017) (26)
Subsidizing Health Insurance for Low-Income Adults: Evidence from Massachusetts (2017) (26)
Productivity Dispersion in Medicine and Manufacturing. (2016) (25)
The Effect of Medicaid on Dental Care of Poor Adults: Evidence from the Oregon Health Insurance Experiment. (2018) (22)
What Good Is Wealth Without Health? (2009) (22)
The Oregon health insurance experiment: when limited policy resources provide research opportunities. (2013) (20)
Market Design in Regulated Health Insurance Markets : Risk Adjustment vs . Subsidies (2018) (20)
Screening and Selection: The Case of Mammograms (2019) (20)
The Challenges of Universal Health Insurance in Developing Countries: Evidence from a Large-Scale Randomized Experiment in Indonesia (2019) (20)
Randomized trial shows healthcare payment reform has equal-sized spillover effects on patients not targeted by reform (2020) (17)
Randomize evaluations to improve health care delivery (2015) (17)
Voluntary Regulation: Evidence from Medicare Payment Reform (2020) (17)
The Challenges of Universal Health Insurance in Developing Countries: Experimental Evidence from Indonesia's National Health Insurance (2021) (16)
Myth and Measurement - The Case of Medical Bankruptcies. (2018) (16)
Insurance Experiment : Evidence from the First Year (2011) (14)
Pricing Efficiently in Designed Markets: The Case of Ride-Sharing∗ (2019) (14)
Long-Term Care Hospitals: A Case Study in Waste (2018) (14)
Preference Heterogeneity and Insurance Markets : Explaining a (2008) (13)
Welfare Analysis Meets Causal Inference: A Suggested Interpretation of Hendren (2018) (12)
Multiple Dimensions of Private Information: Evidence from the Long-Term Care Insurance Market. (2006) (12)
Effects of medicaid on clinical outcomes. (2013) (12)
Is American Pet Health Care (Also) Uniquely Inefficient? (2016) (10)
Finishing College: The Role of State Policy in Degree Attainment (2005) (9)
Minimum Standards and Insurance Regulation: Evidence from the Medigap Market (2002) (8)
The IO of Selection Markets (2021) (8)
Comment on "Mind the Gap! Consumer Perceptions and Choices of Medicare Part D Prescription Drug Plans" (2010) (7)
When Can Partial Public Insurance Produce Pareto Improvements? (2002) (6)
Using Randomized Evaluations to Improve the Efficiency of US Health Care Delivery (2015) (6)
Moral Hazard in Health Insurance Developments Since Arrow (1963) (2014) (6)
The market for private long-term care insurance (2007) (4)
A Strategy for Improving U.S. Health Care Delivery - Conducting More Randomized, Controlled Trials. (2020) (4)
A Taste of Their Own Medicine: Guideline Adherence and Access to Expertise (2021) (4)
The Economic Consequences of Hospital Admissions. (2018) (3)
Financial Incentives to Facilities and Clinicians Treating Patients With End-stage Kidney Disease and Use of Home Dialysis (2022) (3)
Selection and asymmetric information in insurance markets (2011) (3)
Appendix For Input and Technology Choices in Regulated Industries : Evidence from the Health Care Sector ( Not for Publication ) (2008) (3)
Out of the Woodwork: Enrollment Spillovers in the Oregon Health Insurance Experiment (2020) (3)
Asymmetric information in insurance markets : evidence and explanations from the long-term care insurance market (2003) (3)
Why is End-of-Life Spending So High? Evidence from Cancer Patients (2020) (3)
Producing Health: Measuring Value Added of Nursing Homes (2022) (2)
Health Care Hotspotting - A Randomized, Controlled Trial. Reply. (2020) (2)
Minimum Standards and Health Insurance Regulation: The Case of Medigap (2000) (2)
What Drives Risky Prescription Opioid Use? Evidence from Migration (2022) (2)
Flowers of Invention: Patent Protection and Productivity Growth in US Agriculture (2021) (2)
Myth and Measurement - The Case of Medical Bankruptcies. (2018) (2)
The Response of Drug Expenditure to Contract Design in Medicare Part D (2013) (2)
The Effects of Information and Application Assistance on Take-up, Targeting, and Welfare: Experimental Evidence from SNAP (WP-18-03) (2018) (2)
Adverse selection and government intervention in life and health insurance markets (2001) (1)
The Review of Economics and Statistics (2013) (1)
The changing focus of public economics research, 1980 - 2010 (2012) (1)
The Economic Consequences of Hospital Admissions (WP-16-24) (2016) (1)
Increasing Health Insurance Costs and the Decline in Health Insurance Coverage (2009) (1)
Preliminary. Do Not Cite or Circulate Without Permission. Comments Welcome Adverse Selection and the Choice of Risk Factors in Insurance Pricing: Evidence from the U.K. Annuity Market (2005) (1)
Subsidies and the Dynamics of Selection: Experimental Evidence from Indonesia's National Health Insurance (2020) (1)
NBER WORKING PAPER SERIES IN PRAISE OF MODERATION: SUGGESTIONS FOR THE SCOPE AND USE OF PRE-ANALYSIS PLAN FOR RCTS IN ECONOMICS (2020) (1)
Beyond Causality: Additional Benefits of Randomized Controlled Trials for Improving Health Care Delivery. (2021) (1)
Take-Up Evaluation (2019) (0)
Productivity Dispersion in Medicine and Manufacturing article openly available. Please share how this access benefits you. Your story matters (2019) (0)
Essays in political economy (2017) (0)
Patent Protection, Invention, and Productivity Growth∗ (2020) (0)
The Impact of Medicare Bundled Payments: Evidence from a Nationwide Randomized Evaluation for Lower Extremity Joint Replacement (2018) (0)
American Economic Association Did Medicare Induce Pharmaceutical Innovation ? (2008) (0)
This paper was produced as part of the Centre's Productivity and Innovation Programme. The Centre for Economic Performance is financed by the Economic and Social Research Council. (2011) (0)
Replication data for: Health Care Spending and Utilization in Public and Private Medicare (2019) (0)
Empirical Analyses of Selection and Welfare in Insurance Markets: A Self-Indulgent Survey (2023) (0)
Treatment Choice and Outcomes for End Stage Renal Disease: Evidence from the First Year of a Nationwide Randomized Evaluation (2021) (0)
PRELIMINARY AND INCOMPLETE: DO NOT CITE Connecting Theory to Data in Analyzing Social Insurance∗ (2011) (0)
Replication Data (2019) (0)
Comments and Discussion (2020) (0)
Online Appendix (2019) (0)
Defending Against Environmental Insults (2011) (0)
Targeting Precision Medicine: Evidence from Prenatal Screening PRELIMINARY ... SOME PARTS ARE STILL INCOMPLETE/IN-PROGRESS (2022) (0)
Comment on "The Demand for Medicare Part D Prescription Drug Coverage: Evidence from Four Waves of the Retirement Perspectives Survey" (2011) (0)
Risky Business (2023) (0)
The Effects of Voluntary Regulation on a Nationwide Medicare Bundled Payment Reform in the United States (2022) (0)
Selection on moral hazard in health insurance Citation (2012) (0)
Report of the Editor: American Economic Review: Insights (2018) (0)
Replication data for: Private Provision of Social Insurance: Drug-Specific Price Elasticities and Cost Sharing in Medicare Part D (2019) (0)
Targeting Precision Medicine: Evidence from Prenatal Screening (2022) (0)
NBER WORKING PAPER SERIES THE ECONOMIC CONSEQUENCES OF HOSPITAL ADMISSIONS (2016) (0)
Heterogeneity in Damages from A Pandemic (2022) (0)
EFFECT ON MARKET EQUILIBRIUM: NEW EVIDENCE FROM LONG-TERM CARE INSURANCE (2003) (0)
Replication data for: The Economic Consequences of Hospital Admissions (2019) (0)
American Economic Association Dynamic Inefficiencies in Insurance Markets : Evidence from Long-Term Care Insurance (2008) (0)
Report: Ad Hoc Search Committee for the Editor of the American Economic Journal: Economic Policy (2013) (0)
The Impact of Bundled Payments on Medicare Spending, Utilization, and Quality in the United States (2021) (0)
Preliminary*and*incomplete.*do*not*cite*or*circulate*without*permission* * 0* * Healthcare Exceptionalism? Productivity and Allocation in the U.s. Healthcare Sector + * Preliminary*and*incomplete.*do*not*cite*or*circulate*without*permission* * 1* * (2012) (0)
The Health Wedge and Labor Market Inequality (2023) (0)
Amy Finkelstein: 2012 John Bates Clark Medalist (2012) (0)
NBER WORKING PAPER SERIES TARGETING PRECISION MEDICINE: EVIDENCE FROM PRENATAL SCREENING (2022) (0)
Essays on Residential Desegregation by Maisy Wong (2009) (0)
Defending Against Environmental Insults: Drugs, Emergencies, Deaths, and the NOx Emissions Markets PRELIMINARY AND INCOMPLETE (2011) (0)
Economic Research Initiative on the Uninsured CONFERENCE DRAFT Dynamic Inefficiencies in Employment-Based Health Insurance System : Theory and Evidence (2007) (0)
Testing: Empirical Models of Insurance Markets (2009) (0)
EZ-Tax : Tax Salience and Tax Rates Citation (2009) (0)
DATAWATCH The Effect Of Medicaid On Medication Use Among Poor Adults : Evidence From Oregon Oregon ’ s 2008 Medicaid expansion significantly increased the use of prescription medications in 2009 – 10 (2017) (0)
The risk of losing health insurance in the United States is large, and remained so after the Affordable Care Act. (2023) (0)
Health Insurance and the Growth of Health Spending: Evidence from the Introduction of Medicare (2004) (0)
EVIDENCE FROM CHILDHOOD IMMIGRANTS (2012) (0)

This paper list is powered by the following services:

Other Resources About Amy Finkelstein

What Schools Are Affiliated With Amy Finkelstein?

Amy Finkelstein is affiliated with the following schools: